Yu-qing Z. Xie
Basel, BS, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
A synthetic angiotensin II/ACE2-based hormone shunt controlling experimental hypertension.
Journal: Nature communications
Published: September 01, 2025
Synthetic closed-loop gene circuit for phenylalanine regulation.
Journal: Nucleic acids research
Published: May 19, 2025
Generating potent and persistent antitumor immunity via affinity-tuned CAR-T cells targeting mesothelin.
Journal: Acta pharmacologica Sinica
Published: January 01, 2025
Plasmid-based electroporation for efficient genetic engineering in immortalized T lymphocytes.
Journal: Metabolic engineering
Published: November 12, 2024
A closed-loop cholesterol shunt controlling experimental dyslipidemia.
Journal: Cell metabolism
Published: October 22, 2024
T cell-redirecting antibody for treatment of solid tumors via targeting mesothelin.
Journal: Acta pharmacologica Sinica
Published: February 22, 2024
Ultrashort-Peptide-Responsive Gene Switches for Regulation of Therapeutic Protein Expression in Mammalian Cells.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 04, 2023
A novel bispecific antibody drug conjugate targeting HER2 and HER3 with potent therapeutic efficacy against breast cancer.
Journal: Acta pharmacologica Sinica
Published: November 16, 2023
The type 2 cytokine Fc-IL-4 revitalizes exhausted CD8+ T cells against cancer.
Journal: Nature
Published: May 29, 2023
Aberrant hyperexpression of the RNA binding protein FMRP in tumors mediates immune evasion.
Journal: Science (New York, N.Y.)
Published: November 17, 2022
Switchable immune modulator for tumor-specific activation of anticancer immunity.
Journal: Science advances
Published: September 13, 2021
Last Updated: 09/26/2026